Marksans Pharma Ltd
NSE:MARKSANS
Marksans Pharma Ltd
NSE:MARKSANS
Price:
145.65 INR
-1.95%
Market Closed
Updated:
Jun 3, 2024
Marksans Pharma Ltd
EPS (Diluted)
|
Marksans Pharma Ltd
EPS (Diluted) Peer Comparison
Comparables:
DRREDDY
CIPLA
SUNPHARMA
ZYDUSLIFE
T
TORNTPHARM
Competitive EPS (Diluted) Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | EPS (Diluted) | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Marksans Pharma Ltd
NSE:MARKSANS
|
EPS (Diluted)
₹7
|
CAGR 3-Years
13%
|
CAGR 5-Years
36%
|
CAGR 10-Years
10%
|
|
|
Dr Reddy's Laboratories Ltd
NSE:DRREDDY
|
EPS (Diluted)
₹334
|
CAGR 3-Years
42%
|
CAGR 5-Years
23%
|
CAGR 10-Years
N/A
|
|
|
Cipla Ltd
NSE:CIPLA
|
EPS (Diluted)
₹51
|
CAGR 3-Years
20%
|
CAGR 5-Years
22%
|
CAGR 10-Years
11%
|
|
|
Sun Pharmaceutical Industries Ltd
NSE:SUNPHARMA
|
EPS (Diluted)
₹37
|
CAGR 3-Years
55%
|
CAGR 5-Years
21%
|
CAGR 10-Years
11%
|
|
|
Zydus Lifesciences Ltd
NSE:ZYDUSLIFE
|
EPS (Diluted)
₹38
|
CAGR 3-Years
22%
|
CAGR 5-Years
16%
|
CAGR 10-Years
17%
|
|
T
|
Torrent Pharmaceuticals Ltd
NSE:TORNTPHARM
|
EPS (Diluted)
₹44
|
CAGR 3-Years
7%
|
CAGR 5-Years
13%
|
CAGR 10-Years
11%
|
See Also
What is Marksans Pharma Ltd's EPS (Diluted)?
EPS (Diluted)
7
INR
7
INR
Based on the financial report for Dec 31, 2023, Marksans Pharma Ltd's EPS (Diluted) amounts to 7 INR.
What is Marksans Pharma Ltd's EPS (Diluted) growth rate?
EPS (Diluted) CAGR 10Y
10%
10%
Over the last year, the EPS (Diluted) growth was 34%. The average annual EPS (Diluted) growth rates for Marksans Pharma Ltd have been 13% over the past three years , 36% over the past five years , and 10% over the past ten years .
You don't have any saved screeners yet
